Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | CCR5 | P51681 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | MIF | P14174 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.34 |
| ▸ | HRH1 | P35367 | 1/20 | 0.34 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.34 |
| ▸ | NOS3 | P29474 | 1/20 | 0.34 |
| ▸ | NOS2 | P35228 | 1/20 | 0.34 |
| ▸ | CTSD | P07339 | 1/20 | 0.34 |
| ▸ | CTSE | P14091 | 1/20 | 0.34 |
| ▸ | BACE1 | P56817 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1403770 | 0.84 | AOC3 (0.40) | LMNACCR5TAAR1CYP2D6TSHR | |
| SCHEMBL169508 | 0.79 | LMNA (0.56) | LMNACCR5TAAR1CYP2D6MIF | |
| SCHEMBL22555481 | 0.78 | NR1I2 (0.44) | HTR2A | |
| Hypochlorous Acid SCHEMBL11415854 | 0.78 | LMNA (0.56) | LMNACCR5TAAR1CYP2D6TSHR | |
| SCHEMBL1533152 | 0.77 | FFAR1 (0.44) | CYP2D6MIFTSHRAOC3TDP1 | |
| Ammonia Solution, Strong SCHEMBL1640901 | 0.77 | LMNA (0.54) | LMNACCR5TAAR1CYP2D6MIF | |
| SCHEMBL9716574 | 0.76 | LMNA (0.41) | LMNACCR5TAAR1CYP2D6MIF | |
| SCHEMBL2237751 | 0.76 | LMNA (0.48) | LMNACCR5TAAR1CYP2D6MIF | |
| SCHEMBL8964015 | 0.76 | LMNA (0.48) | LMNACCR5TAAR1CYP2D6MIF | |
| Methylamine SCHEMBL27931105 | 0.75 | LMNA (0.52) | LMNACCR5TAAR1CYP2D6HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2405982-B1 | METHODS FOR REMOVING VICINAL DIOLS FROM LACTIC ACID FERMENTATION BROTH | DOW CORNING (US) | 2013-12-18 | — | — | EP | disclosed |
| US-8293939-B2 | Methods for removing vicinal diols from lactic acid fermentation broth | DOW CORNING CORPORATION (US) | 2012-10-23 | — | — | US | disclosed |
| US-20120029231-A1 | METHODS FOR REMOVING VICINAL DIOLS FROM LACTIC ACID FERMENTATION BROTH | DOW CORNING CORPORATION (US) | 2012-02-02 | — | — | US | disclosed |
| EP-2405982-A2 | METHODS FOR REMOVING VICINAL DIOLS FROM LACTIC ACID FERMENTATION BROTH | Dow Corning Corporation (US) | 2012-01-18 | — | — | EP | disclosed |
| WO-2010104677-A2 | METHODS FOR REMOVING VICINAL DIOLS FROM LACTIC ACID FERMENTATION BROTH | DOW CORNING CORPORATION (US) | 2010-09-16 | — | — | WO | disclosed |
| US-20090030222-A1 | SYSTEMS AND METHODS FOR FUNCTIONALIZING PARTICULATES WITH SILANE-CONTAINING MATERIALS | DOW CORNING CORPORATION | 2009-01-29 | — | — | US | disclosed |
| EP-1979422-A2 | SYSTEMS AND METHODS FOR FUNCTIONALIZING PARTICULATES SILANE-CONTAINING MATERIALS | Dow Corning Corporation (US) | 2008-10-15 | — | — | EP | disclosed |
| WO-2007084245-A2 | SYSTEMS AND METHODS FOR FUNCTIONALIZING PARTICULATES SILANE-CONTAINING MATERIALS | DOW CORNING CORPORATION (US) | 2007-07-26 | — | — | WO | disclosed |
| WO-2005034205-A2 | SELF ASSEMBLING NANOPARTICLE-POLYMER HYBRIDS | DOW CORNING CORPORATION (US) | 2005-04-14 | — | — | WO | disclosed |
| EP-0665256-A2 | Pristine phenylpropylalkylsiloxanes | DOW CORNING CORPORATION (US) | 1995-08-02 | — | — | EP | disclosed |
| US-5384383-A | Pristine phenylpropylalkylsiloxanes | DOW CORNING CORPORATION (US) | 1995-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120029231-A1 | METHODS FOR REMOVING VICINAL DIOLS FROM LACTIC ACID FERMENTATION BROTH | SORD, LDHA, LDHB | LMNA 1216/4885CCR5 2068/4885TAAR1 1346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.